各种技术可以解决含有氧化和偏醇的组合制药剂型的重叠紫外线光谱
Samar S Elbaramawi1, Sobhy M El-Adl1, Alaa Nafea1
1Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
BMC chemistry
|May 28, 2024
概括
开发了10种新的光谱测量方法来分析氧化和. 这些经过验证的技术提供了准确和精确的药物分析,有助于制药质量控制.
科学领域:
- 分析化学 分析化学
- 药品分析 药品分析
背景情况:
- 药物化合物的精确量化对于药物的安全性和有效性至关重要.
- 现有的分析方法可能需要优化,以便对氧化和类药物进行常规的质量控制.
研究的目的:
- 开发和验证十种新的光谱测光方法,用于定量确定氧化和.
- 为了比较拟议的分析技术的性能和统计有效性.
主要方法:
- 开发了十种光谱光度计方法,包括零顺序,导数,比率和数学技术.
- 根据国际协调理事会 (ICH) 的指导方针验证所有开发的方法.
- 拟议方法与报告方法的统计比较.
主要成果:
- 发现所有十种开发的光谱光度计方法都是特定的,准确的,精确的和强大的.
- 方法证明了可接受的验证参数,包括线性,检测极限和量化极限.
- 统计分析证实了拟议的药物分析方法的适用性.
结论:
- 该研究成功地建立了十种新的,经过验证的光谱光度测量方法,用于氧化和类的分析.
- 这些方法为药品质量控制提供了可靠,高效和准确的替代方案.
- 这些发现提供了各种光谱光度计方法的综合比较,用于药物确定.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
129
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
129
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
299
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
299
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
124
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
124
Factors Influencing Drug Absorption: Physicochemical Parameters
258
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
258
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K


